Financials
- Market Capitalization 402.54 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.14
Relación precio/flujo de caja
26.03
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3054 | ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 14.82 USD | -8.35% | +11.26% | +157.74% | -12.98% | 421.23 M USD | ||
| 3056 | GALT Galectin Therapeutics Inc. - Common Stock | 4.07 USD | -1.69% | +9.41% | +18.66% | -3.10% | 410.46 M USD | ||
| 3063 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 12.37 USD | +5.10% | +8.03% | +22.96% | +38.06% | 433.78 M USD | ||
| 3071 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.80 USD | -3.81% | -2.24% | +9.34% | -0.21% | 393.82 M USD |